Meet the Legal Team Fighting the DEA to Save Psychedelic Research – Psychedelics Today
This entry has been published on October 24, 2024 and may be out of date.
We are grateful to Psychedelics Today for educating the community about the importance of DOI & DOC.
“I have many colleagues who work with these compounds who will testify in the upcoming hearing, and that is only a subset of the research community,” said Elijah Ullman, Chair of SSDP’s Science Policy Council who has been interested in science policy since he was a teen.
Ullman added, “The DEA alleges that DOI and DOC should be placed in Schedule 1 because of their high potential for abuse, but this does not align with over 40 years of data.”
